ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Acceler8 Clinical Research Limited

Acceler8 Clinical Research Limited is an active company incorporated on 2 March 2022 with the registered office located in Knutsford, Cheshire. Acceler8 Clinical Research Limited was registered 3 years ago.
Status
Active
Active since incorporation
Company No
13949356
Private limited company
Age
3 years
Incorporated 2 March 2022
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 25 April 2025 (6 months ago)
Next confirmation dated 25 April 2026
Due by 9 May 2026 (5 months remaining)
Last change occurred 3 years ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Micro Entity
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 1 month remaining)
Address
Unit 1, Mere View Barn Park Lane
Pickmere
Knutsford
WA16 0LG
England
Address changed on 1 May 2024 (1 year 6 months ago)
Previous address was Booths Hall, Suite M3 Chelford Road Knutsford WA16 8GS England
Telephone
01565 756190
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
2
Controllers (PSC)
1
Director • British • Lives in England • Born in Apr 1971
Director • British • Lives in UK • Born in Feb 1964
Mr Ewan James Campbell
PSC • British • Lives in England • Born in Feb 1964
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
The Lighthouse Trust
Ewan James Campbell is a mutual person.
Active
Arithmostech Limited
Ewan James Campbell is a mutual person.
Active
Zosi Life Sciences Ltd
Ewan James Campbell is a mutual person.
Active
The Pharmaceutical Code Company Ltd
Ewan James Campbell is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2023–2025)
Period Ended
31 Mar 2025
For period 31 Mar31 Mar 2025
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
3
Same as previous period
Total Assets
£172.86K
Increased by £16.77K (+11%)
Total Liabilities
-£60.78K
Decreased by £72.83K (-55%)
Net Assets
£112.08K
Increased by £89.6K (+398%)
Debt Ratio (%)
35%
Decreased by 50.43% (-59%)
Latest Activity
Micro Accounts Submitted
3 Months Ago on 8 Aug 2025
Confirmation Submitted
6 Months Ago on 25 Apr 2025
Mrs Kerri Clare Campbell Details Changed
6 Months Ago on 25 Apr 2025
Micro Accounts Submitted
11 Months Ago on 10 Dec 2024
Confirmation Submitted
1 Year 6 Months Ago on 14 May 2024
Registered Address Changed
1 Year 6 Months Ago on 1 May 2024
Micro Accounts Submitted
1 Year 11 Months Ago on 1 Dec 2023
Confirmation Submitted
2 Years 5 Months Ago on 31 May 2023
Confirmation Submitted
3 Years Ago on 20 May 2022
Kerri Clare Campbell (PSC) Resigned
3 Years Ago on 19 May 2022
Get Credit Report
Discover Acceler8 Clinical Research Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Micro company accounts made up to 31 March 2025
Submitted on 8 Aug 2025
Director's details changed for Mrs Kerri Clare Campbell on 25 April 2025
Submitted on 25 Apr 2025
Confirmation statement made on 25 April 2025 with no updates
Submitted on 25 Apr 2025
Micro company accounts made up to 31 March 2024
Submitted on 10 Dec 2024
Confirmation statement made on 14 May 2024 with no updates
Submitted on 14 May 2024
Registered office address changed from Booths Hall, Suite M3 Chelford Road Knutsford WA16 8GS England to Unit 1, Mere View Barn Park Lane Pickmere Knutsford WA16 0LG on 1 May 2024
Submitted on 1 May 2024
Micro company accounts made up to 31 March 2023
Submitted on 1 Dec 2023
Confirmation statement made on 20 May 2023 with no updates
Submitted on 31 May 2023
Second filing of a statement of capital following an allotment of shares on 19 May 2022
Submitted on 20 May 2022
Cessation of Kerri Clare Campbell as a person with significant control on 19 May 2022
Submitted on 20 May 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year